GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Total Liabilities

Medipost Co (XKRX:078160) Total Liabilities : ₩161,686 Mil (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Total Liabilities?

Medipost Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩161,686 Mil.

Medipost Co's quarterly Total Liabilities increased from Jun. 2024 (₩132,973.84 Mil) to Sep. 2024 (₩134,943.19 Mil) and increased from Sep. 2024 (₩134,943.19 Mil) to Dec. 2024 (₩161,686.30 Mil).

Medipost Co's annual Total Liabilities declined from Dec. 2022 (₩215,213.13 Mil) to Dec. 2023 (₩135,735.22 Mil) but then increased from Dec. 2023 (₩135,735.22 Mil) to Dec. 2024 (₩161,686.30 Mil).


Medipost Co Total Liabilities Historical Data

The historical data trend for Medipost Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Total Liabilities Chart

Medipost Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102,896.20 91,900.31 215,213.13 135,735.22 161,686.30

Medipost Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135,735.22 135,150.22 132,973.84 134,943.19 161,686.30

Medipost Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medipost Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=81497.758+(7617.808+70578.784
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1314.2+677.753)
=161,686

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=414287.47-252601.167
=161,686

Medipost Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=81497.758+(7617.808+70578.784
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1314.2+677.753)
=161,686

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=414287.47-252601.167
=161,686

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipost Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Medipost Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co Business Description

Traded in Other Exchanges
N/A
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co Headlines

No Headlines